Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

NCT03392168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: ARQ-151 cream 0.5%
DRUG: ARQ-151 cream 0.15%
DRUG: ARQ-151 vehicle cream

Sponsor

Arcutis Biotherapeutics, Inc.